[1]
“Maintenance therapy with oral etoposide following first-line docetaxel-cisplatin chemotherapy in metastatic non-small cell lung cancer patients”, Bangladesh J Pharmacol, vol. 7, no. 3, pp. 192–198, Sep. 2012, doi: 10.3329/bjp.v7i3.11656.